Budget Impact of Rivaroxaban for the Prevention of Thromboembolic Events after Hip or Knee Replacement in Spain

por Granero Xiberta, Xavier, Murcia, Antonio, Troncoso Durán, José Ricardo, Gómez Zubeldia, Claudio, Llorac Moix, Aleix, Graefenhain De Codes, Ruth, Ferrario, Maria Giovana, Lizán, Luis
Publicado 2016

Real-world cost-effectiveness analysis of NOACs versus VKA for stroke prevention in Spain

por Escobar Cervantes, Carlos, Martí-Almor, Julio, Cabeza, Alejandro Isidoro Pérez, Bowrin, Kevin, Llorac Moix, Aleix, Genís Gironès, Mar, Gasche, David, Millier, Aurélie, Tardu, Jean, Toumi, Mondher, Briere, Jean-Baptiste
Publicado 2022